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Supplementary Table 1.  Characteristics of the SAC Study population, stratified by 
whether FeNO was obtained  
Variable Without  FeNO 
(N=57) 
With FeNO 
(N=131) 
P Value 
Age (years) 6.7 10.6 <0.001 
WBC 12.4 12.0 0.49 
Hb (g/dL) 8.2 8.3 0.53 
Reticulocyte (%) 11.2 11.0 0.80 
Eosinophil (median) 2.5 3.0 0.87 
IgE  (median) 69.6 49.6 0.60 
Male (%) 50.9 55.0 0.61 
Maternal history of asthma (%) 23.2 10.3 0.02 
History of inhaled corticosteroid use (ever) 
(%) 
14.0 20.6 0.29 
History of hydroxyurea use (ever) (%) 38.6 32.8 0.44 
History of wheezing leading to shortness of 
breath (%) 
28.1 24.4 0.60 
History of asthma (%) 28.1 29.0 0.90 
Rate of ACS prior to baseline (median) (%)  .20 .12 0.10 
Rate of pain prior to baseline (median) (%) .14 .29 0.03 
Prospective rate of ACS after baseline 
(median) (%) 
.00 .00 0.42 
Prospective rate of pain after baseline 
(median) (%) 
.14 .49 <0.01 
Abbreviations: SAC: Sleep and Asthma Cohort; FeNO: exhaled nitric oxide; FVC: forced 
vital capacity; FEV1=forced expiratory volume in 1 second; WBC=white blood cell count; Hb 
= hemoglobin; ACS=acute chest syndrome 
 
  
 Supplementary Table 2. Associations between FeNO and Participant Characteristics, 
Stratified by Asthma Status  
Categorical variables 
 All subjects 
N=131 
No Asthma 
N=93 
Has Asthma 
N=38 
 Median 
FeNO 
 Median 
FeNO 
 Median 
FeNO 
 
Covariate  No Yes P 
valuea 
No Yes P value No Yes P value 
Male gender 8.4 10.3 0.11 8.3 9.9 0.13 8.6 11.2 0.63 
Parent has asthma 8.7 10.6 0.14 8.3 11.8 <0.05 9.9 8.7 0.65 
Participant has asthma 8.9 9.9 0.60       
On hydroxyurea at the 
time of FeNO 
8.7 11.4 0.06 8.7 18.2 0.16 9.2 11.4 0.65 
On inhaled 
corticosteroids at the 
time of FeNO 
8.8 11.7 0.25 8.9 8.4 0.62 9.0 17.4 0.05 
Has ≥12% 
improvement in FEV1 
after bronchodilator 
9.0 10.0 0.50 9.0 6.9 0.34 9.0 17.4 0.05 
Had 2 more positive 
skin tests (N=121) 
8.3 12.4 0.001 8.1 11.8 0.01 8.8 12.6 0.03 
Wheeze with cold 8.7 10.0 0.22 8.9 8.2 0.98 9.1 11.4 0.28 
Wheeze without cold 9.0 10.4 0.30 9.8 7.8 0.14 7.9 12.5 0.07 
Wheeze with SOB 9.0 9.4 0.70 8.9 8.0 0.58 8.4 11.2 0.29 
Wheeze after exercise 8.9 9.8 0.66 9.4 8.7 0.43 11.8 9.2 0.47 
Had an ACS event 
prior to 4 years of age 
9.8 9.0 0.45 8.1 10.1 0.28 13.3 8.7 0.12 
Had a pain event prior 
to 4 years of age 
8.9 9.6 0.95 8.3 9.9 0.13 8.6 11.2 0.63 
Continuous Variables 
 All subjects No Asthma Has Asthma 
Covariate b P value  P value  P value 
Age .28 0.001 .27 0.009 .31 0.06 
Height .34 <0.001 .30 0.004 .43 0.007 
FEV1% predicted -.07 0.46 -.10 0.33 .02 0.89 
FVC% predicted -.04 0.63 -.11 0.31 .07 0.67 
FEV1/FVC (actual) -.09 0.32 -.01 0.90 -.23 0.17 
FEV1/FVC (% predicted)
  .00 0.95 .05 0.62 -.08 0.65 
IgE .28 0.001 .25 0.02 .37 0.02 
Eosinophils, total no. of cells/cu.mm .20 0.02 .18 0.08 .23 0.17 
White blood cell count -.08 0.35 -.07 0.51 -.11 0.51 
Hemoglobin (g/dL) .02 0.84 .15 0.16 -.25 0.13 
Retrospective rate of ACS prior to FeNO -.03 0.78 -.02 0.84 -.17 0.32 
Retrospective rate of pain prior to FeNO -.03 0.76 .05 0.62 -.18 0.27 
Prospective rate of ACS after FeNO .07 0.42 .07 0.53 .03 0.87 
Prospective rate of pain after FeNO .01 0.87 -.02 0.82 .04 0.79 
Abbreviations: FeNO=exhaled nitric oxide; ppb=parts per billion; FVC=forced vital capacity; 
FEV1=forced expiratory volume in 1 second; ACS=acute chest syndrome 
aWilcoxon rank sum P value 
bSpearman correlation coefficient 
 
 
Supplementary Table 3.  Multivariable model of factors associated with (ln)FeNO among 
children with SCA, stratified by asthma status 
 No Asthma Asthma 
Covariates β Estimate (SE) P value β Estimate (SE) P value 
Male gender 0.24 (0.13) 0.07 -0.02 (0.23) 0.94 
White blood cell count -0.02 (0.02) 0.15 -0.03 (0.04) 0.50 
(ln) IgE 0.10 (0.04) 0.03 0.15 (0.07) 0.03 
Eosinophils  
     (quartile 1 = reference) 
     Quartile 2 
     Quartile 3 
     Quartile 4 
 
 
0.03 (0.17) 
0.35 (0.19) 
0.45 (0.18) 
 
 
0.88 
0.07 
0.01 
 
 
-0.69 (0.35) 
-0.45 (0.27) 
-0.17 (0.34) 
 
 
0.05 
0.10 
0.61 
History of wheezing that 
caused shortness of breath 
-0.40 (0.18) 0.03 0.19 (0.24) 0.42 
ACS episode prior to 4 years 
of age 
-0.07 (0.15) 0.63 -0.26 (0.20) 0.22 
Abbreviations: FeNO=exhaled nitric oxide; SCA= sickle cell anemia; SE=standard error; 
ACS=acute chest syndrome 
 
  
 Supplementary Table 3. Multivariable model of prospective rates of ACS in Children 
with SCA, stratified by Asthma Status 
 No Asthma Has Asthma 
Covariate IRR 95% CI P value IRR 95% CI P value 
ln (FeNO):           1.64 1.06-2.54 0.03 1.24 0.80-1.93 0.34 
Male gender 0.56 0.30-1.05 0.07 0.61 0.31-1.20 0.15 
History of wheezing causing 
shortness of breath 
2.42 1.06-5.49 0.04 2.02 1.13-3.62 0.02 
ACS episode prior to age 4 
years 
1.71 0.92-3.18 0.03 5.52 2.85-10.71 <0.001 
Abbreviations: ACS=acute chest syndrome ; SCA=sickle cell anemia; IRR=incidence rate 
ratio; CI=confidence interval; FeNO=exhaled nitric oxide; SCA= sickle cell anemia; 
SE=standard error;  
aNegative Binomial regression models with adjustment for over-dispersion, using robust 
standard errors. Two-tailed significance values.   
 
